• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

印度成人疫苗接种:现状与未来方向。

Adult vaccination in India: status and the way forward.

机构信息

Department of Health Systems Development, World Health Organization Country Office for India , New Delhi, India.

Department of Community & Family Medicine, All India Institute of Medical Sciences (AIIMS) , Jodhpur, India.

出版信息

Hum Vaccin Immunother. 2020 Jul 2;16(7):1508-1510. doi: 10.1080/21645515.2019.1692564. Epub 2019 Dec 6.

DOI:10.1080/21645515.2019.1692564
PMID:31743073
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7482772/
Abstract

In the last two decades, the childhood vaccination coverage in most low and middle-income countries including India has increased. Additional vaccines are being offered through national immunization programs as well as through private sector and the benefits of vaccination are reaching to more children than ever. This has resulted in major decrease in vaccine preventable diseases and contributed to decline in the morbidity and mortality rates. This development is expected to result in epidemiological transition (which is already happening) and mandates for policies and strategies to extend the benefit of available vaccines and vaccination beyond traditionally target age groups to include the adults, elderly and the at-risk populations. This article reviews the present status of adult vaccination in India and proposes a few approaches to move towards life course vaccination.

摘要

在过去的二十年中,包括印度在内的大多数低收入和中等收入国家的儿童疫苗接种覆盖率有所提高。国家免疫规划、私营部门也提供了更多疫苗,疫苗的益处比以往任何时候都惠及更多儿童。这使得疫苗可预防疾病的发病率显著下降,发病率和死亡率也有所降低。这一发展预计将导致流行病学转变(这种转变已经在发生),并需要制定政策和战略,将现有疫苗和接种的益处扩大到传统目标年龄组之外,包括成年人、老年人和高危人群。本文回顾了印度目前的成人疫苗接种现状,并提出了一些方法,以迈向全生命周期疫苗接种。

相似文献

1
Adult vaccination in India: status and the way forward.印度成人疫苗接种:现状与未来方向。
Hum Vaccin Immunother. 2020 Jul 2;16(7):1508-1510. doi: 10.1080/21645515.2019.1692564. Epub 2019 Dec 6.
2
Role of the private sector in vaccination service delivery in India: evidence from private-sector vaccine sales data, 2009-12.印度私营部门在疫苗接种服务提供中的作用:来自2009 - 2012年私营部门疫苗销售数据的证据
Health Policy Plan. 2016 Sep;31(7):884-96. doi: 10.1093/heapol/czw008. Epub 2016 Mar 14.
3
Towards adult vaccination in India: a narrative literature review.迈向印度成人疫苗接种:叙事文献综述。
Hum Vaccin Immunother. 2020 Apr 2;16(4):991-1001. doi: 10.1080/21645515.2019.1682842. Epub 2019 Dec 2.
4
Adult vaccination in India: A rapid review of current status & implementation challenges.印度的成人疫苗接种:当前状况与实施挑战的快速回顾
Indian J Med Res. 2024;160(3&4):279-292. doi: 10.25259/IJMR_1521_2024.
5
Status of immunization and need for intensification of routine immunization in India.印度免疫状况和常规免疫强化的必要性。
Indian Pediatr. 2012 May;49(5):357-61. doi: 10.1007/s13312-012-0081-x.
6
Private sector vaccine share in overall immunization coverage in India: Evidence from private sector vaccine utilization data (2012-2015).印度整体免疫覆盖率中的私营部门疫苗份额:来自私营部门疫苗利用数据的证据(2012-2015 年)。
Indian J Public Health. 2020 Jan-Mar;64(1):75-78. doi: 10.4103/ijph.IJPH_433_18.
7
[Immunization coverage of children aged 0 to 5 years in Libreville (Gabon)].[加蓬利伯维尔0至5岁儿童的免疫接种覆盖率]
Sante. 2010 Oct-Dec;20(4):215-9. doi: 10.1684/san.2010.0204. Epub 2011 Jan 25.
8
Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2003 to 2006.2003年至2006年澳大利亚原住民和托雷斯海峡岛民中的疫苗可预防疾病及疫苗接种覆盖率
Commun Dis Intell Q Rep. 2008 Jun;32 Suppl:S2-67.
9
Ensuring childhood vaccination among slums dwellers under the National Immunization Program in India - Challenges and opportunities.确保印度国家免疫计划下贫民窟居民的儿童接种疫苗 - 挑战与机遇。
Prev Med. 2018 Jul;112:54-60. doi: 10.1016/j.ypmed.2018.04.002. Epub 2018 Apr 4.
10
Demand-side determinants of timely vaccination of oral polio vaccine in social mobilization network areas of CORE Group polio project in Uttar Pradesh, India.印度北方邦 CORE 集团脊髓灰质炎项目社会动员网络地区口服脊髓灰质炎疫苗及时接种的需求方决定因素。
BMC Infect Dis. 2018 May 16;18(1):222. doi: 10.1186/s12879-018-3129-2.

引用本文的文献

1
Vaccine-Preventable Diseases in Pediatric Age Group in India: Recent Resurgence, Implications and Solutions.印度儿童年龄组中可通过疫苗预防的疾病:近期的再度流行、影响及解决方案
Indian J Pediatr. 2025 Apr 25. doi: 10.1007/s12098-025-05531-9.
2
Developments and Trends of Immunization in India: A Narrative Review.印度免疫接种的发展与趋势:叙述性综述
Cureus. 2024 Aug 9;16(8):e66547. doi: 10.7759/cureus.66547. eCollection 2024 Aug.
3
From both sides of the needle: Understanding effective interventions for facilitating non-national immunization program vaccine decision making in China.从针的两侧:了解中国促进非国家免疫规划疫苗决策的有效干预措施。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2389578. doi: 10.1080/21645515.2024.2389578. Epub 2024 Aug 22.
4
Need for a robust public health response to seasonal influenza in India.印度需要针对季节性流感做出强有力的公共卫生应对措施。
Indian J Med Res. 2023 May;157(5):421-426. doi: 10.4103/ijmr.ijmr_184_23.
5
Characteristics and economic burden of hospitalized patients with herpes zoster in China, before vaccination.中国带状疱疹住院患者的特征和经济负担,在疫苗接种前。
Hum Vaccin Immunother. 2023 Dec 15;19(3):2268990. doi: 10.1080/21645515.2023.2268990. Epub 2023 Oct 30.
6
Factors Influencing Monkeypox Vaccination: A Cue to Policy Implementation.影响猴痘疫苗接种的因素:政策实施的线索。
J Epidemiol Glob Health. 2023 Jun;13(2):226-238. doi: 10.1007/s44197-023-00100-9. Epub 2023 Apr 29.
7
Basic Lessons From India on Vaccination [Letter to the Editor].印度在疫苗接种方面的基本经验教训[致编辑的信]
Rambam Maimonides Med J. 2023 Apr 30;14(2):e0012. doi: 10.5041/RMMJ.10499.
8
Intention to Vaccinate against COVID-19 among Young Adults: The Role of Conspiratorial Thinking.年轻人接种新冠疫苗的意愿:阴谋论思维的作用。
Vaccines (Basel). 2023 Jan 31;11(2):321. doi: 10.3390/vaccines11020321.
9
Need to Study the Health Impact and Economics of Adult Vaccination with India in Focus.需要聚焦印度研究成人疫苗接种对健康的影响及经济学意义。
Indian J Community Med. 2022 Oct-Dec;47(4):471-475. doi: 10.4103/ijcm.ijcm_1333_21. Epub 2022 Dec 14.
10
Disparities in Coverage of Adult Immunization among Older Adults in India.印度老年人成人免疫接种覆盖率的差异。
Vaccines (Basel). 2022 Dec 12;10(12):2124. doi: 10.3390/vaccines10122124.

本文引用的文献

1
Towards adult vaccination in India: a narrative literature review.迈向印度成人疫苗接种:叙事文献综述。
Hum Vaccin Immunother. 2020 Apr 2;16(4):991-1001. doi: 10.1080/21645515.2019.1682842. Epub 2019 Dec 2.
2
Efficacy, effectiveness, and safety of herpes zoster vaccines in adults aged 50 and older: systematic review and network meta-analysis.带状疱疹疫苗在 50 岁及以上成人中的疗效、效果和安全性:系统评价和网络荟萃分析。
BMJ. 2018 Oct 25;363:k4029. doi: 10.1136/bmj.k4029.
3
Status and trend of acute encephalitis syndrome and Japanese encephalitis in Bihar, India.印度比哈尔邦急性脑炎综合征和日本脑炎的现状与趋势
Natl Med J India. 2017 Nov-Dec;30(6):317-320. doi: 10.4103/0970-258X.239070.
4
'Ayushman Bharat' Program and Universal Health Coverage in India.印度的“阿育吠陀·巴拉特”计划与全民健康覆盖
Indian Pediatr. 2018 Jun 15;55(6):495-506.
5
"Health system approach" for improving immunization program performance.用于提高免疫规划绩效的“卫生系统方法”
J Family Med Prim Care. 2015 Oct-Dec;4(4):487-94. doi: 10.4103/2249-4863.174263.
6
The Evolution of the Meningitis Vaccine Project.脑膜炎疫苗项目的发展历程。
Clin Infect Dis. 2015 Nov 15;61 Suppl 5(Suppl 5):S396-403. doi: 10.1093/cid/civ594.
7
A brief history of vaccines & vaccination in India.印度疫苗与疫苗接种简史。
Indian J Med Res. 2014 Apr;139(4):491-511.
8
An assessment of hepatitis B vaccine introduction in India: Lessons for roll out and scale up of new vaccines in immunization programs.印度乙型肝炎疫苗引入评估:免疫规划中新疫苗推出和扩大规模的经验教训。
Indian J Public Health. 2013 Jan-Mar;57(1):8-14. doi: 10.4103/0019-557X.111357.
9
Introduction of Haemophilus influenzae type b (Hib) as pentavalent(DPT-HepB-Hib) vaccine in two states of India.在印度两个邦引入b型流感嗜血杆菌(Hib)五价疫苗(白百破-乙肝-Hib)。
Indian Pediatr. 2012 Sep;49(9):707-9. doi: 10.1007/s13312-012-0151-0.
10
India's National Technical Advisory Group on Immunisation.印度国家免疫技术咨询小组。
Vaccine. 2010 Apr 19;28 Suppl 1:A88-90. doi: 10.1016/j.vaccine.2010.02.041.